Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2011

View Archived Issues

Researchers describe discovery and development of hepatitis C treatment GS-5885

Scientists present two new agents against herpes simplex virus

FDA approves use of Edurant in treatment-naive adults with HIV-1

PMX-30063 shows activity against oral mucositis in animal study

PRM-151 is safe and active in healthy volunteers and in subjects with idiopathic pulmonary fibrosis

PF-4357415 is superior to fluticasone propionate in rat model of lung inflammation

Phase II data disclosed on tanezumab in chronic prostatitis/chronic pelvic pain syndrome

First patients enrolled in phase I trial of Glycotope's FSH-GEX

Thermo Fisher Scientific signs definitive agreement to acquire Phadia

Novartis confirms new divisional structure following merger with Alcon

Themis Bioscience raises funds to advance vaccine candidates

New delta opioid receptor antagonists reported by Janssen group

KIST presents novel protein kinase inhibitors for cancer

Merck & Co. describes new phosphodiesterase 10A inhibitors

New closthioamides presented

Scientists prepare new adenosine A2A receptor antagonists

Sosei launches NorLevo emergency contraceptive pill in Japan

FDA approves Incivek for genotype 1 chronic hepatitis C

Nexavar plus standard chemotherapy improves progression-free survival of patients with breast cancer

Genentech reports phase II data on MetMAb/Tarceva in NSCLC

Gactiv approved in Japan for type 2 diabetes in combination with alpha-glucosidase inhibitors

VivaGel is efficacious in phase II trial in bacterial vaginosis

Abbott to submit ALK FISH test for approval in Japan and U.S.

Daiichi Sankyo and AstraZeneca enter copromotion agreement for denosumab in Japan

EMA's CHMP recommends label extension for tocilizumab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...